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ABSTRACT 
Carbon nanotubes (CNTs) are at present being considered as potential nanovectors with the ability to deliver 
therapeutic cargoes into living cells. Previous studies established the ability of CNTs to enter cells and their 
therapeutic utility, but an appreciation of global intracellular trafficking associated with their cellular distribution 
has yet to be described. Despite the many aspects of the uptake mechanism of CNTs being studied, only a few 
studies have investigated internalization and fate of CNTs inside cells in detail. In the present study, intracellular 
localization and trafficking of RNA-wrapped, oxidized double-walled CNTs (oxDWNT–RNA) is presented. Fixed 
cells, previously exposed to oxDWNT–RNA, were subjected to immunocytochemical analysis using antibodies 
specific to proteins implicated in endocytosis; moreover cell compartment markers and pharmacological inhibitory 
conditions were also employed in this study. Our results revealed that an endocytic pathway is involved in the 
internalization of oxDWNT–RNA. The nanotubes were found in clathrin-coated vesicles, after which they appear 
to be sorted in early endosomes, followed by vesicular maturation, become located in lysosomes. Furthermore, 
we observed co-localization of oxDWNT–RNA with the small GTP-binding protein (Rab 11), involved in their 
recycling back to the plasma membrane via endosomes from the trans-golgi network. 
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1. Introduction 
The mechanisms that control cellular uptake and release 
of carbon nanotubes (CNTs) are currently poorly 
understood. So far, besides the demonstration of the 
ability of CNTs to enter and penetrate cell membranes 
[1–4], the uptake mechanism is still debated and may 
involve more than one process. Indeed, Kam et al. 
and Jin et al. reported that protein or single-stranded 
oligonucleotide-modified CNTs could enter cells by 
means of endocytosis [5, 6]. In contrast, Kostarelos et 
al. suggested that an energy-independent non-endocytic 
mechanism is involved in the insertion and diffusion  
of CNTs through different cellular barriers [2].  
Address correspondence to H.Coley@surrey.ac.uk 
Endocytosis is a frequent cellular event that transfers 
extracellular or membrane-bound cargoes, such as 
nutrients, from the plasma membrane into the cell 
interior by vesicular transport. In this process, endocytic 
vesicles form invaginations of the plasma membrane 
that subsequently pinch off, move internally, and 
fuse with other endocytic vesicles to form the early 
endosomal compartment. The endocytic process may 
involve so-called clathrin-coated pits (i.e., associated 
with a clathrin-dependent process). Clathrin forms  
a complex network in the form of a lattice that is  
built up to form a coat. Alternatively, there may be 
clathrin-independent endocytotic processes involved 
in cellular trafficking. The early endosome is the major 
sorting station in the endocytic pathways. From this 
organelle, material can be directed toward the pathway 
of recycling to the plasma membrane, to subsequent 
endocytic compartments and to regulated secretory 
vesicles [7]. Transferrin for example, a monomeric iron 
transporting serum glycoprotein, is processed in the 
late endosome, after which the transferrin receptors are 
recycled by a recycling endosome [8]. The recycling 
endosome is typically less acidic (pH 6.4–6.5) than the 
sorting endosome (pH 6.0) and exhibits a peri- 
centriolar localization [9]. Late endosomes contain 
active degradative enzymes; however, these are more 
concentrated in the lysosomes. The transfer of 
material between late endosomes and lysosomes 
appears to be a direct fusion event that results in a  
transient hybrid organelle [10].  
Each step in endocytosis is independently regulated 
by the interaction of multiple proteins. These include 
several small GTP-binding proteins of the Rab family. 
These proteins have been particularly examined 
because of their effectiveness as molecular markers 
for various types of endosomes. Rab 5, an example of 
such GTPase-associated activity [11], regulates the 
rate of clathrin-dependent endocytosis at the plasma 
membrane and can be used as a marker for early 
sorting endosomes in addition to or in conjunction 
with the transferrin receptor. Rab 11 localizes to a 
pericentriolar subpopulation of recycling endosomes 
[12]. It is pertinent to point out that the process of 
endocytosis is a complex process that has yet to be 
completely defined despite significant progress in  
understanding its various components. 
Identification of the mode by which CNTs move 
between cellular compartments after their inter- 
nalization, and the sites in which they localize has 
been thus far been accomplished by simple staining 
of lysosomes by pH-dependent markers (e.g., 
LysoTracker® red) [5, 13], by transmission electron 
microscopy (TEM) [13–15], or by pharmacological 
inhibition of the endocytic pathway [2, 5]. Kam et al. 
[5] were the first to describe an energy-dependent 
mechanism. In their studies, clathrin-mediated 
endocytosis was proven by experiments carried out 
under inhibitory conditions, such as the presence of 
sucrose and a potassium-depleted medium, which 
revealed a significantly reduced level of CNT uptake. 
Using TEM, Yehia et al. 2007 observed that single- 
walled carbon nanotubes (SWNTs) dispersed in 
medium were endocytosed and localized in the plasma 
membrane, cytoplasm, endosomes, lysosomes, and 
golgi bodies [16]. A similar methodology was used by 
Mu et al. 2009, who proposed a working model for cell 
uptake of multi-walled carbon nanotubes (MWNTs) 
modified by carboxylation or amidation, using TEM 
imaging [15]. In their model, CNTs were not only 
internalized via endocytic pathways, but also through 
membrane penetration, depending on whether CNTs 
were present as bundles or highly dispersed single 
CNTs, respectively [15]. After both internalization via 
endocytosis or membrane penetration, CNTs were 
found in lysosomes, followed by their extrusion [15]. 
However, no data were presented on the mechanism 
of exocytosis. In 2009, Jin et al. presented the first 
evidence for exocytosis of CNTs, which was found to 
closely match the endocytic rate [13]. Furthermore, a 
study in our group demonstrated the time-dependent  
loss of CNTs by cells [4]. 
In contrast to the endocytic pathway, Lacerda et al. 
reported for the first time that membrane penetration 
of CNTs (SWNTs modified via cycloaddition) can 
lead to their accumulation in the perinuclear region 
of mammalian cells [17]. In addition, another study 
performed by Zhou et al. in 2010 also showed an 
endocytosis-independent mechanism for non-covalently 
modified SWNTs [18]. In their studies, incubations at 
4 °C and in the presence of sodium azide (NaN3) were 
carried out, which failed to prevent CNTs from being  
internalized.  
 In spite of the considerable effort to elucidate the 
uptake mechanism of CNTs and their intracellular 
localization, an appreciation of global intracellular 
trafficking has yet to be clarified. Herein we attempt 
to complete this study using organelle-specific markers 
to describe and to identify the mechanisms through 
which CNTs are transported as they enter and 
eventually efflux from in vitro-cultured human prostate  
cancer cells. 
2. Results and discussion 
Double-walled carbon nanotube (DWNT) cellular 
uptake and release has been previously demonstrated 
by our group using Raman spectroscopy [4]. However, 
it is also imperative to understand their intracellular 
route and subcellular localizations during their transit 
through cells. Hence, this study presents a detailed 
methodology using confocal microscopy in com- 
bination with organelle-specific markers to examine 
the intracellular distribution of CNTs. In addition, 
pathway-inhibitory drugs were used to identify 
major processes through which CNTs traffic as they 
enter and eventually efflux from cells. For this purpose, 
fluorescently labelled RNA-wrapped oxidized DWNTs  
(oxDWNTs) were employed.  
2.1 Characterization of CNT complexes 
CNT complexes were characterized using microscopic 
techniques, in particular atomic force microscopy 
(AFM) and TEM. Figure 1(a) depicts an AFM scan 
over a surface of fluorescein–RNA-wrapped oxidized 
DWNTs (oxDWNT–RNA–FS). Furthermore, the TEM 
image in Fig. 1(b) depicts individualized CNTs with  
noticeable two-wall characteristics of the DWNTs.  
Raman spectroscopy is a useful tool for the 
identification of CNTs in a sample, since they have 
characteristic Raman features. Figure 1(c) shows the 
Raman spectra of pristine DWNTs and oxDWNT– 
RNA–FSs. The first visible peaks are the radial 
breathing modes (RBMs), caused by uniaxial vibrations, 
which depend linearly on the nanotube diameter; 
these can be found between 150–300 cm–1. The RBM 
is then followed by the disorder-induced D-band 
between 1250 and 1450 cm–1, the tangential mode (or 
G-band), which is caused by stretching along the C–C 
bonds, between 1590–1600 cm–1 [19–21], and finally 
the G′-band, a two-phonon mode ~2700 cm–1 away 
from the excitation wavelength [19]. The spectra in 
Fig. 1(c) demonstrate that the D-band intensity increases 
during the oxidation process; nevertheless the D/G 
ratio is overall still rather low due to the preservation  
of the structure of the inner tube. 
Figure 1(d) exhibits the Raman signal of cells 
exposed to oxDWNT–RNA–FS and cells as a control. 
To determine if cells internalized the full complex of 
oxDWNTs, RNA, and fluorescein, the same slides that  
 
Figure 1 Characterization of CNT complexes. AFM (a) and TEM 
(b) images of fluorescently labelled RNA-wrapped oxidized DWNTs 
(oxDWNT–RNA–FS). (c) Raman spectra of pristine DWNTs and 
oxDWNT–RNA–FS. The ratio D/G band  has increased for  
oxDWNT–RNA–FS samples due to  acid ox idation. (d)  Raman 
spectroscopy of cells exposed to oxDWNT–RNA–FS and control 
(cells only) 
 were used for fluorescence microscopy were used for 
Raman spectroscopy. The results (Fig. 1(d)) show that 
the G-band, which is a characteristic signature band 
for CNTs, can be clearly observed in the Raman 
spectrum of cells exposed to oxDWNT–RNA–FS, thus 
confirming successful cellular uptake. Furthermore, 
we have shown in an independent study by our group 
based on Raman spectroscopy that RNA-wrapped 
oxidized DWNTs are internalized and released by 
cells in a time-dependent manner [4]. In particular, cells 
were exposed to CNTs for 3 h, corresponding with 
maximal intake, after which CNTs were removed 
from the surrounding medium and the release of 
CNTs from the cells monitored for further 21 h. The 
study showed that CNTs were released progressively 
over this time frame up until the end point of the 
experiment (24 h), when no CNT-signal could be  
measured any longer inside the cells [4].  
The stability of oxidized and RNA-wrapped CNTs 
in biological fluids, as well as their cytotoxicity, has 
also been previously examined in our group [22]. In 
that study it was shown that oxidized CNTs are 
relatively stable in cellular growth medium and that 
additional wrapping with RNA further increased their 
stability in human plasma. Moreover, it was found 
that cells incubated with oxidized, RNA-wrapped 
CNTs were 75% viable [22]. Although RNA-wrapping 
is potentially prone to degradation in cellular growth 
medium or the cell interior, it was demonstrated by 
others that siRNA-wrapped CNTs readily enter cells 
and that the siRNA remains biologically active in the 
cell even in the presence of serum [23], which is very 
likely due to the fact that CNTs can protect single- 
stranded nucleic acids from enzymatic cleavage and 
intracellular interference from nucleic acid binding  
proteins [24]. 
2.2 Cellular internalization of CNT complexes  
Confocal microscopy was used to demonstrate the 
internalization of fluorescently labelled CNTs. PC3 
human prostate cancer cells were incubated with 
30 g/mL of oxDWNT–RNA–FS for 2 h. This incubation 
period was chosen based on previous papers on endo- 
and exocytosis of carbon nanotubes, for example by 
Jin et al., who observed maximal cellular uptake of 
CNTs between 1 h and 2 h [13]. Subsequently, cells were 
fixed to prevent morphologic changes and inhibit 
further natural cellular transport, which “traps” CNTs 
in the various cellular compartments, in which they are 
located at the time. This provides a snapshot of the 
intracellular distribution of CNTs after internalization 
and release have reached a steady state: while some 
CNTs are just being internalized, others are already  
being sorted in lysosomes, or even exocytosed.  
Figure 2 reveals that incubation of PC3 human 
prostate cancer cells with oxDWNT–RNA–FS produced 
readily detectable fluorescence in the cytoplasm (green) 
in the same plane as the nucleus, but not in the nucleus 
itself (counterstained in blue). The cytoskeleton, which 
is involved in coordinating the organization and 
dynamics of intracellular architecture and therefore 
relevant to the further understanding of membrane 
trafficking was stained with phalloidin (red). Cell 
morphology appeared regular after exposure to 
CNTs and inhibitory drugs, and no obvious signs   
of artefactual cellular damage or associated toxicity 
with the procedures used throughout this work were  
observed.  
To determine the cellular compartments in which 
CNT complexes localize and traffic between, organelle- 
specific antibodies were employed. After fixation to 
prevent morphological changes, cells were incubated 
with primary antibodies specific to certain proteins (e.g., 
clathrin) and then a fluorescently labeled secondary 
antibody was employed specific to the source of the  
primary antibody (e.g., rabbit). 
The internalization via the endocytic route involves 
a cascade of intracellular events, with different vesicles 
and regulators. The observation of CNT complexes in 
intracellular endosome-like structures (Fig. 2) suggested 
that an endocytic pathway was involved in the 
internalization of the complexes. Therefore, it was 
decided to use markers such as clathrin and caveolin 
involved in the first step of endocytosis, invagination 
of the cell membrane, to elucidate which endocytosis 
mechanism in particular is responsible for CNT 
uptake. Clathrin-mediated endocytosis is characterized 
by membrane-bound vesicles inside a coat composed 
 primarily of the fibrous protein clathrin. In contrast, 
caveolae are plasma membrane invaginations that 
are enriched in cholesterol and sphingolipids. In 
addition, these invaginations also accumulate special 
cholesterol-binding proteins, termed caveolins, on 
the cytosolic face of vesicles [25–28]. Certain ligands, 
which are internalized via caveolae, are likely to be 
delivered to a special endosomal compartment referred 
to as a “caveosome” [29]. Caveosomes containing 
caveolins do not transport/co-localize transferrin, 
lack EEA1 and other early endosomal markers, have 
neutral pH, and can act as sorting stations [26]. 
Figure 2(c) shows co-localization of the CNT complexes 
(green) with clathrin (red); but no co-localization with  
caveolin (Fig. 2(b)). 
Generally, newly formed plasma membrane-derived 
endocytic vesicles lose their clathrin coat and fuse with 
each other or with pre-existing compartments known 
as sorting endosomes [30, 31]. The first endosomal 
compartment, the sorting or early endosome, has a 
role in sorting the cargo for further transport. The 
early endosome can be identified using an early 
endosome antigen (EEA1) in combination with a 
fluorescent secondary antibody. Our data show that 
CNT complexes are closely associated with this location, 
as seen via co-localization studies of CNT complexes  
(green) with EEA1 (red) (Fig. 2(d)). 
The drop in the pH within the sorting endosome 
dissociates many ligands from their receptor, allowing 
those receptors to be recycled back to the plasma 
membrane. As previously described, small GTPases 
have emerged as central regulators of vesicle budding, 
motility, and fusion. One of these proteins is Rab 4, 
involved in the recycling back to the plasma mem- 
brane from the early endosome. However, our results 
suggest that Rab 4 does not have a function in the 
trafficking of CNT complexes through the cell, as no  
co-localization was observed (Fig. 2(e)). 
Maturation of sorting endosomes into late endosomes 
or multivesicular bodies is coincidental with a drop 
of the pH. The endosome becomes incapable to commit 
further fusion with vesicles from the cell surface or 
other sorting endosomes, thus preventing new cargoes 
and receptors from being inadvertently degraded by 
‘joining’ a late endosome as it matures into/fuses 
with a lysosome [27]. The lysosome can be identified 
using antibodies for lysosome membrane proteins 
(LMP). LMPs reside mainly in the lysosomal limiting 
membrane and have diverse functions, including 
acidification of the lysosomal lumen, protein import 
from the cytosol, membrane fusion and transport of 
degradation products to the cytoplasm. The most 
abundant LMPs are the lysosome-associated membrane 
protein 1 (LAMP1), LAMP2, lysosomal integral 
membrane protein 2 (LIMP2) and the tetraspanin 
CD63 [28]. As demonstrated in Fig. 2(f), a high level 
of co-localization was observed with LAMP2 (selected 
for our co-localization studies), thus indicating that 
CNT complexes end up in the lysosomes after being  
endocytosed. 
The recycling endosome not only allows for the 
recycling of plasma membrane components (a branch 
of the pathway that might need to be avoided in the 
context of drug delivery) but also enables the cell   
to traffic molecules back to the trans-golgi network 
(TGN/Golgi) [29]. Again, Rab proteins have been 
found to regulate this transport, especially the Rab 11 
GTPase complex. Figure 2(g) shows co-localization of 
Rab 11 and the CNT complexes, indicating that they 
reach the vesicles from the secretory pathway and are 
delivered by Rab 11-positive vesicles. The trans-golgi 
trafficking, in which Rab 11 is involved may be further 
validated using antibodies for the golgi97 protein, 
which localizes on the trans side of the golgi apparatus. 
It is believed to participate in the trafficking of vesicles 
between the golgi stacks and the trans-golgi network 
[32]. This additional analysis, however, exceeded the  
scope of this paper. 
In addition to co-localization with a clathrin-specific 
antibody, CNT complexes also co-localized with trans- 
ferrin (Fig. 2(h)). Transferrin is a monomeric serum 
glycoprotein that binds iron. After its recognition at 
the cell surface by transferrin receptors, transferrin is 
internalized via clathrin-dependent endocytosis. Inside 
endosomes, the acidic environment favours dissociation 
of iron from the transferrin. After sorting in late 
endosomes, transferrin then reaches the golgi apparatus 
and is subsequently recycled back to the plasma 
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membrane. The co-localization of CNTs with this 
protein further confirms that they are internalized via 
clathrin-dependent endocytosis and that they undergo  
sorting in late endosomes.  
Fluorescence microscopy can furthermore be used 
as a semi-quantitative estimate of the pH in endocytic 
structures in cell culture models by staining with 
pH-sensitive dyes, such as the LysoTracker® dyes. 
This dye stains acidic compartments in live cells, in 
particular the lysosomes. Thus, in combination with 
LAMP2 antibody staining it provides further con- 
firmation of the sequestration of CNT complexes in 
lysosomes. As demonstrated in Fig. 2(i), there is an 
overlap between LysoTracker® (red) and CNT com- 
plexes (green), indicating that the CNT complexes are 
located in an acidic compartment. A more detailed 
analysis including co-localization profiles of selected 
regions can be found in Fig. S-2 in the Electronic  
Supplementary Material (ESM). 
It is important to note that confocal microscopy 
does not provide sufficient resolution to observe single 
nanotubes, which have been shown to traffic within 
cells in an entirely different fashion (bundles are mainly 
taken up by endocytosis, whereas single nanotubes 
can pierce though the membrane of the cell and also 
those of intracellular organelles) [15, 18]. In addition, 
 
Figure 2 Subcellular distr ibution of CNT  complexes in  PC3 cells . Cells were incubated with  30 g/mL of ox DWNT–RNA–FS fo r 
2 h. (a) Cells stained for pr esence of  actin filaments (red) w ith Alexa Fluor® 546 Phalloidin and with T O-PRO®-3 for nuclei (bl ue) 
prior to being imaged for CNT complex accumulation (green). (b)–(i) Co-localization of CNT complexes (green) with antibody-specific 
and com partmental m arkers (r ed) in PC3 cel ls. Co-loca lization was observed for clathrin- positive vesicl es ( c); EEA1- positive earl y 
endosomal vesicles (d); Lamp2-positive lysosomes (f); Rab 11-positive recycling endosomes (g); transferrin (h); and LysoTracker® red
(i). Yellow colour (arrows) indicates cell compartments positive for both CNT complexes and organelle markers. Counterstaining was 
not observed for caveolin (b) and Rab 4 (e) 
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cellular uptake of CNTs is strongly influenced by the 
type of functionalization used. While the surface charge 
of CNTs (i.e., carboxylated (–) and amine-terminated 
(+) CNTs) did not seem to have an effect on cellular 
uptake due to heavy protein coating leading to 
compensation of the surface charges [15], it has been 
observed that the attachment of a large molecule, for 
example the protein bovine serum albumin (BSA), can  
direct cellular uptake towards endocytosis [18]. 
2.3 Effect of pathway inhibitory drugs on localization 
of CNT-complexes  
A systematic analysis of intracellular transport 
pathways is readily achieved by analysing the effects 
of inhibiting one or more transport processes. A widely 
used method for inhibiting transport is to apply a 
temperature block to cells [30]. Most transport pro- 
cesses, including clathrin-dependent internalization, 
will be blocked at 4 °C. Endocytosis is an energy- 
dependent mechanism that is also hindered when 
incubations are carried out in ATP-depleted environ- 
ments, as attained by incubation with 10 mmol/L 
sodium azide (NaN3). In our experiments (Figs. 3(b) 
and 3(c)), both incubation at 4 °C and with NaN3 
resulted in inhibition of uptake of CNT complexes in 
PC3 cells, suggesting an energy-dependent mechanism  
for their internalization. 
Pharmacological inhibition of cellular trafficking 
can be achieved with the compound LY294002, which 
is an inhibitor of phosphoinositide 3-kinase (PI-3 
kinase). PI-3 kinases are a family of enzymes involved 
in signal transduction and membrane trafficking, as 
well as other molecular processes. Trafficking processes 
that are inhibited by LY294002 include translocation 
to the plasma membrane [33, 34], endocytosis [35, 36], 
endosome fusion [31], lysosomal protein sorting 
[37, 38], transcytosis [39], and autophagy [40]. The 
compound 3-methyladenine is a specific inhibitor of 
autophagic sequestration [41] that also inhibits PI-3 
kinase. When either LY294002 or 3-methyladenine 
were employed in our study, we observed a blockage 
of membrane traffic and endosome fusion, which 
prevented CNT complexes from being internalized  
by PC3 cells (Figs. 3(d) and 3(e)).  
 
Figure 3 Effect of  inh ibitory conditions fo r endocytic up take. 
Cells were expo sed to 30 g/mL of oxDWNT–RNA–FS for 2 h 
and the effects of various (pre)-treatments on CNT internalization 
were studied (a). incubation at 4 °C (b); pre-incubation with sodium 
azide (NaN 3) (c) ; pre- incubation with phosphoinositide 3-kinase 
inhibitor (LY294002) (d); pre-incubation with 3-methyladenine (e). 
Actin filaments (red) were stained with Alexa Fluor® 546 Phalloidin 
and nuclei (blue) with TO-PRO®-3 
3 Conclusions 
The objective of the present study was to elucidate the 
mechanism of uptake of CNTs, as well as to determine 
the intracellular compartments in which they localize. 
From the data presented herein we propose an 
endocytic route for uptake and trafficking of CNT 
complexes (functionalized by means of oxidation and 
wrapping with RNA). Figure 4 schematically represents 
the intermediate stations of CNT complexes during  
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Figure 4 Proposed intracellular trafficking of CNT complexes. 
The internalization of oxDWNT–RNA–FS-complexes was prove n 
to be energy-dependent as it could be blocked by incubation at 4 °C 
and pre-incubation with NaN3 (Figs. 3(b) and 3(c)). Additionally, 
incubation with  PI-3 kin ase inhibitors, known to interfer e with  
vesicular traf ficking, led to r educed in ternalization of CN Ts 
(Figs. 3(d) and 3(e)) . Co-lo calization with b oth c lathrin and 
transferrin prov ided evidence fo r clathr in-mediated endocy tosis 
(Figs. 2(c) and 2 (h)), after which CNT complexes undergo sorting 
in the  ear ly e ndosomes (co-loca lization wi th E EA1—Fig. 2(d)). 
CNT com plexes are then s equestrated in th e l ysosomes, a s 
confirmed by Lamp2 and  LysoTracker® staining (Figs. 2(f) and 
2(i), respectively). CNTs were also found within vesicles  of the 
secretory pathway (Rab 11-positive vesicles), which for the first 
time suggests an exact route for their exocytosis (Fig. 2(g)) 
their passage through PC3 cells. Evidence of their 
intracellular localization was demonstrated by Raman 
spectroscopy and fluorescence spectroscopy of exposed 
cells. The CNT complexes were found to be endocytosed 
by capture in clathrin-coated vesicles as revealed by 
clear co-localization with both clathrin and transferrin. 
These results are in agreement with the work reported 
by Kam et al. [5], who also found evidence for clathrin- 
mediated endocytosis as an uptake mechanism for 
CNTs. Molecules entering cells via endocytic pathways 
will rapidly experience a drop in pH from neutral  
to pH 5.9–6.0 in the lumen of early/recycling vesicles 
with further reduction from pH 6.0 to pH 5.0 during 
progression from late endosomes to lysosomes [32]. 
In our studies, CNT complexes were found in early 
endosomes as confirmed by co-localization with early 
endosome antigen (EEA). CNT complexes were not 
sorted for recycling back to the cell membrane (via fast 
recycling endosomes), as co-localization with Rab 4 
was not observed; instead, co-localization with both 
LAMP2 antibody and LysoTracker® marker indicated 
their sequestration in lysosomes. In addition, CNT 
complexes were also found within Rab 11-positive  
vesicles of the secretory pathway.  
Overall, our study brings novel findings on the 
uptake and traffic of CNTs in mammalian cells, 
allowing identification of the uptake pathway and the 
cellular organelles, in which CNTs localize. Additionally, 
exocytosis was once again confirmed with additional 
identification of the key organelle responsible for 
CNTs efflux: it is reported for the first time that the 
recycling endosomes from the trans-golgi network (Rab 
11-positive vesicles) are responsible for extracellular  
extrusion of CNTs.  
4 Experimental 
4.1 Preparation of fluorescently labelled oxidized 
DWNTs 
DWNTs synthesized by the CCVD (catalytic chemical 
vapor deposition) technique [42] were purified in 
concentrated nitric acid and oxidized in a mixture of 
nitric and sulphuric acids [43]. In the first step, 100 mg 
of CNTs were dispersed in 20 mL of concentrated nitric 
acid, sonicated with a tip sonicator (MSE Soniprep 
150, amplitude 8 µm) six times for 10 s, and incubated 
in a water bath (Grant ultrasonic bath XB2, Farnell, UK) 
at 95 °C for 2 h. After oxidation, the acid was diluted 
with water and the mixture centrifuged (10 min at 
50 000 g, 4 °C) (Beckman Avanti J25, Buckinghamshire, 
UK), followed by thorough washing with distilled 
water. These pre-treated CNTs were then redispersed 
in a 3:1 mixture of concentrated nitric and sulphuric 
acids and the above described process repeated. 
Afterwards, the oxidized CNTs were vacuum-filtered 
using a 0.2 µm polycarbonate filter (Whatman Ltd., 
UK) until the eluate was clear and of neutral pH. The 
filtrate was then sonicated with a tip sonicator six  
 9
times for 10 s and centrifuged three times at 75 000 g 
to remove large agglomerates and CNT bundles. The 
concentration of these dispersions was determined 
gravimetrically and adjusted to 100 µg/mL for storage 
in the fridge at 4 °C. After oxidation, nanotubes were 
sterilized by autoclaving at 121 °C for 1 h and were 
maintained under sterile conditions for the duration 
of the experiment. In a second step, the oxDWNTs 
were biofunctionalized by wrapping with fluorescently  
labelled RNA as described below.  
Biofunctionalization of oxDWNTs with RNA was 
achieved using ready-made fluorescently labelled RNA 
(Eurofins—MWG Operon), with the oligonucleotide 
sequence (5′) CAUUCCGAGUGUCCACAUUCCGA 
GUGUCCA-FLU (3′) (RNA–FS). The manufacturer 
details states that the oligonucleotide has a molecular 
weight of 10 052 g/mol, Tm of 69.5 °C, GC-content of 
53.3% and has been purified by high-performance liquid 
chromatography (HPLC). A solution of 1.0 mg/mL 
(prepared in sterile water) was diluted 1:5 in a solution 
of oxDWNTs at a concentration of 200 g/mL (weight 
ratio CNTs/RNA 1:0.8). After that, the complexes 
were allowed to form by stirring for 2 h at room 
temperature (~21 °C) in the dark. To remove unbound 
RNA–FS, the solution was filtered and washed several 
times using 100 kDa centrifugal filters (Millipore). 
Finally, the oxDWNT–RNA–FS were resuspended in  
sterile water to a final concentration of 200 g/mL. 
Samples were characterized by Raman spectroscopy, 
AFM, and TEM. Raman spectroscopy was performed 
for pristine DWNTs, oxDWNTs–RNA, and cells con- 
taining oxDWNT–RNA–FS, using a Renishaw inVia 
Raman microscope, Elaser=1.59 eV (785 nm wavelength). 
For AFM sample preparation, oxDWNTs were diluted 
with water to obtain a concentration of 10 g/mL. A 
droplet of 2 L was placed onto a freshly cleaved mica 
substrate (1 cm2) and dried in air. AFM measurements 
were performed using a PicoPlus instrument (Agilent 
Technologies, Chandler, AZ) operated in contact mode 
at room temperature with a lateral scan rate of 1–1.5 Hz 
at 512 lines. Data analysis was carried out using 
“Gwyddion 2.9”, a free SPM data visualization and 
imaging tool released under the GNU General Public 
License. Samples for TEM were prepared by dilution 
of the sample in acetone and placing a single drop of 
the solution on a standard copper grid. High resolution 
TEM measurements were performed using a FEI 
Tecnai G2F20 S Twin instrument with an accelerating  
voltage of 200 kV. 
4.2 Cellular incubation with CNTs-complexes and 
compartment staining 
PC3 cells were cultured in RPMI-1640 medium 
supplemented with 10% FBS, 2 mmol/L Glutamax™ 
and 1% penicillin–streptomycin (all obtained from 
Invitrogen, Paisley, UK). Cells were cultured in 24-well 
(13 mm-well) sterile plates (Nunc, Thermo Scientific) 
containing glass coverslips (VWR International, Lutter- 
worth, UK) for 24 h so that they were 50% confluent  
at the time of exposure to CNT complexes. 
4.2.1 Incubation with inhibitory drugs 
For adenosine triphosphate (ATP) depletion studies, 
a phosphate buffered saline (PBS) buffer solution 
supplemented with 10 mmol/L sodium azide (NaN3) 
and 50 mmol/L D-glucose was diluted as a ratio of 1:2 
in complete RPMI medium and incubated with cells 
for 2 h at 37 °C, followed by incubation in a solution 
of CNT complexes. For inhibitory conditions with 
LY294002 (phosphoinositide 3-kinase inhibitor) and 
3-methyladenine (inhibitor of autophagic sequestration), 
cells were incubated overnight with 10 mol/L of drug  
before addition of the CNT complexes.  
4.2.2 Incubation with CNT-complexes 
PC3 cells growing in 24-well plates were incubated 
with 30 g/mL CNT complexes diluted in complete 
RPMI medium. After incubation for 2 h, cells were 
washed twice with sterile PBS (Invitrogen, Paisley, UK) 
and fresh medium added for 5 min. Cells were again 
washed with sterile PBS and treated for 10 min with 
CellScrub (Genlantis, San Diego, USA) washing buffer 
to remove all extracellular CNT complexes. Finally, cells  
were washed twice more with sterile PBS.  
4.2.3 Cell fixation 
To prevent morphological changes and inhibit further 
natural cellular transport, cells were fixed with 4% 
(w/v) paraformaldehyde (Sigma Aldrich, Poole, UK) 
solution in PBS for 1 h at room temperature. Then cells 
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were washed once more with sterile PBS and treated 
with 0.1% v/v Triton X-100 (Sigma Aldrich, Poole, UK)  
in PBS to allow permeabilization of cell membranes. 
4.2.4 Compartment staining (using phalloidin, TO- 
PRO®-3, LysoTracker® red and transferrin) 
Cell membrane-associated actin filaments were stained 
using phallotoxins (Alexa Fluor® 555 Phalloidin— 
emission 565 nm) with a final concentration of 
0.044 mol/L. Transferrin conjugates (Alexa Fluor 
546—emission 573 nm) at a concentration of 20 g/mL 
were applied to stain endosomes associated with 
clathrin-dependent endocytosis, and acidic cell com- 
partments (lysosomes) were stained using LysoTracker 
Red DND-99 (emission 590 nm) at a final concentration 
of 1 mol/L. All agents were diluted from freshly 
made stock solutions in 0.5% bovine serum albumin 
(BSA; Sigma Aldrich) in sterile PBS and applied to 
cells after fixation for a period of 15 min. Cells were 
then washed three times with PBS and finally, 
To-Pro-3 (emission 661 nm), a monomeric cyanine 
nucleic acid stain, was applied in order to visualize 
the cell nuclei in all samples. It was employed as  
the final step of the immunocytochemistry using a 
concentration of 0.1 mol/L in PBS (all reagents from 
Invitrogen-Molecular Probes Corporation, unless stated  
otherwise). 
4.2.5 Immunostaining 
Subsequent to cell fixation and permeabilization, cells 
were incubated for 90 min with primary antibodies 
(Santa Cruz Biotechnology, Inc; supplied by Insight 
Biotechnology; Harrow, UK) diluted in PBS containing 
0.5% BSA, as described in Table 1. Cells were then 
washed three times with PBS and incubated for 1 h 
with fluorescent secondary antibody (Alexa Fluor 
546 from Invitrogen) diluted 1:100 in 0.5% BSA in 
PBS, followed by three 5 min washes in PBS. After 
immunostaining, cells were also stained with To-Pro-3  
as described (above). 
4.2.6 Mounting glass-slides and microscopy 
Following the final step for all samples, in which 
nucleic acids were stained with To-Pro-3, coverslips 
were removed from the 24-well plate using fine forceps 
and were then held vertically against tissue to remove  
Table 1 Immunostaining. Primar y antibodies emplo yed an d 
respective secondary antibodies 
Primary antibody Dilution factor for 
primary antibody
Secondary 
antibody
Clathrin HC (H-300): sc-9069 1:100 Anti-rabbit
Caveolin-1 (N20): sc-894 1:200 Anti-rabbit
Early endosome antigen (EEA1) 
(C15): sc-6414 
1:500 Anti-goat
Lysosome-associated me mbrane 
proteins (Lamp 2) (H4B4): sc-  
18822  
1:2000 Anti-mouse
Ras-related superfamily – Rab  
4/14 (FL-213): sc28569  
1:200 Anti-rabbit
Ras-related superfamily – Rab  
11 (H87): sc-9020 
1:80 Anti-rabbit
 
excess liquid. A small drop of VECTASHIELD® 
Mounting Medium (Vector Laboratories, UK) was 
placed on a glass slide and the coverslip, cells facing 
down, was positioned on top of the Vectashield drop. 
After removing the excess liquid, coverslips were 
sealed using a standard commercially available nail  
lacquer and allowed to dry.  
Images were captured using 63x magnification with 
a Zeiss LSM 510 inverted confocal microscope and  
analysed using LSM 510 META software (Zeiss).  
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